hope rugo, md, examines data from the destiny-breast01 clinical study presented at sabcs 2020
Published 3 years ago • 194 plays • Length 3:31Download video MP4
Download video MP3
Similar videos
-
4:54
hope rugo, md, shares the design and outcomes of keynote-355 presented at sabcs 2020
-
4:50
hope rugo, md, provides perspective on the clinical progress of cdk 4/6 inhibitors in breast cancer
-
1:00:31
inspired | beyond the white coat with dr. hope rugo
-
16:21
dr. hope rugo | san antonio breast cancer symposium 2022 | general session
-
49:25
optimizing therapy in her2 disease with dr. hope s. rugo
-
39:17
5 หลักปฏิบัติเรื่องอาหารช่วงรักษามะเร็ง
-
33:35
which metastatic breast cancer treatment is right for you? what you need to know
-
51:38
medical update: her2-positive and triple-positive metastatic breast cancer
-
15:33
hope s. rugo: first efficacy results from the i - spy 2 trial
-
6:25
hope s. rugo, et al.
-
1:53
dr. hope rugo examines angiogenesis inhibition for advanced breast cancer
-
12:18
hope rugo, md: breast cancer data highlights from emcc 2011
-
10:09
hope rugo, md: advances and challenges in the treatment of metastatic breast cancer
-
6:41
marianne and bolero-1 trial results in breast cancer
-
2:35
dr. rugo on the phase iii sophia trial in her2 breast cancer
-
14:30
new data on role of gene assays in breast cancer treatment - medpage today
-
4:27
study of immunotherapy combinations for patients with her2-positive metastatic breast cancer
-
1:33
dr. hope rugo on the first-line superiority of paclitaxel for advanced breast cancer
-
5:59
trastuzumab deruxtecan for the treatment of her2 breast cancer
-
58:08
metastatic breast cancer update
-
1:29
poziotinib for her2-positive metastatic breast cancer
-
2:25
reducing risk in residual breast cancer